Feb 7, 2023 04:02PM
Feb 7, 2023 04:01PM
Feb 7, 2023 04:01PM
Feb 6, 2023 08:00AM
Feb 6, 2023 08:00AM
Feb 6, 2023 08:00AM
Nov 14, 2022 05:40AM Opiant Pharmaceuticals (OPNT) Acquired by Indivior for up To $28/sh
Nov 14, 2022 02:13AM
Nov 14, 2022 02:12AM
Nov 14, 2022 02:10AM
Oct 27, 2022 04:05PM
Aug 11, 2022 04:05PM
Aug 1, 2022 04:05PM
May 10, 2022 05:01PM Opiant Pharmaceuticals (OPNT) Posts Wider Q1 Loss
May 10, 2022 04:01PM
May 10, 2022 04:01PM
May 3, 2022 08:00AM
May 3, 2022 08:00AM
Apr 27, 2022 04:04PM
Apr 27, 2022 04:01PM
Apr 27, 2022 04:01PM Opiant Pharmaceuticals Announces Positive Topline Results from Head-to-Head Pharmacodynamic Study Comparing OPNT003, Nasal Nalmefene, to Nasal Naloxone
Mar 16, 2022 06:06AM
Mar 15, 2022 04:08PM
Mar 15, 2022 04:05PM
Mar 15, 2022 04:05PM
Mar 7, 2022 04:05PM
Mar 7, 2022 04:05PM
Nov 11, 2021 04:07PM Opiant Pharmaceuticals (OPNT) Tops Q3 EPS by 85c
Nov 11, 2021 04:05PM
Nov 11, 2021 04:05PM
Oct 21, 2021 04:05PM
Oct 21, 2021 04:05PM
Aug 5, 2021 04:01PM
Aug 5, 2021 04:01PM
Jul 22, 2021 04:05PM Opiant Pharmaceuticals to Report Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 5, 2021
Jul 22, 2021 04:05PM
May 11, 2021 04:38PM
May 11, 2021 04:05PM
May 11, 2021 04:05PM
May 3, 2021 04:01PM
May 3, 2021 04:01PM
Mar 4, 2021 04:31PM Opiant Pharmaceuticals (OPNT) Misses Q4 EPS by 23c, Revenues Beat
Mar 4, 2021 04:05PM
Mar 4, 2021 04:05PM
Feb 22, 2021 04:01PM
Feb 22, 2021 04:01PM
Nov 12, 2020 04:35PM
Nov 12, 2020 04:05PM
Nov 12, 2020 04:05PM Opiant Pharmaceuticals Announces Third Quarter 2020 Financial Results and Corporate Update
Oct 27, 2020 04:01PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All